Genentech yields in Patent suit
Genentech Inc. has agreed to pay $200 million to the University of California to end a 10-year dispute over the rights to genetically engineered human growth hormone, sources familiar with the
Genentech Inc. has agreed to pay $200 million to the University of California to end a 10-year dispute over the rights to genetically engineered human growth hormone, sources familiar with the